Therapy to reduce irritability in children with autism
Part of Brain & nervous system, Mental health clinical trials.
This trial studies whether cognitive-behavioral therapy (a structured talk therapy) can reduce irritability and anger outbursts in children with autism. It may help improve day-to-day behavior by teaching coping skills and reducing problem reactions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has been diagnosed with autism spectrum disorder (DSM-5).
- Your child has disruptive irritability—like anger outbursts.
- Your child’s IQ is between 55 and 85.
- Your child scores high enough on an irritability rating (ABC Irritability score 15 or above).
- Your child is not starting new medicines, or is on a stable medication regimen.
- Your child can complete all study check-ins and brain scan (fMRI) procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a therapy program (called CBT) that helps children with autism who also struggle with emotional or behavioral regulation. It aims to reduce emotional outbursts and improve coping while receiving care through community providers.
This study uses a type of talk therapy called cognitive behavioral therapy (CBT) to help reduce anxiety in children who have both autism and an intellectual disability. The goal is to see if this therapy can make a real difference in their daily lives.
This trial tests a type of brain stimulation called theta burst stimulation to see if it helps people with autism who have limited verbal skills or intellectual disability manage their emotions better. It may offer a new way to support emotional well-being.
This trial tests whether mild brain stimulation (TMS) over the temporoparietal junction can improve a social thinking skill called 'mentalizing' in adults with autism. You would have MRI scans, cognitive tasks, and several TMS sessions.
This Phase 2 study tests CBDV, a form of cannabis-based medicine, compared with placebo (dummy medicine) in children with autism who have significant irritability and social challenges. It aims to see whether CBDV can improve behavior and overall symptom severity safely over the study period.
This study tests whether two structured therapies can reduce severe irritability and angry reactions in children and teens. It focuses on youth who have had long-lasting, frequent outbursts and trouble responding to negative emotions.
Hear when a new Autism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.